Skip to Main Content

In a victory for the pharmaceutical industry, a federal appeals court panel ruled that a Maryland state law that was enacted to punish generic drug makers for price gouging is unconstitutional.

In explaining its decision, the panel sided with a trade group for generic drug makers that argued the state law violates interstate commerce by giving Maryland officials the right to govern business outside the state, effectively providing “unprecedented powers to regulate the national pharmaceutical market.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.